Cytokinetics Inc (CYTK)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -496,205 | -324,202 | -186,313 | -93,943 | -98,867 |
| Revenue | US$ in thousands | 7,530 | 72,481 | 53,988 | 39,865 | 20,245 |
| Operating profit margin | -6,589.71% | -447.29% | -345.10% | -235.65% | -488.35% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-496,205K ÷ $7,530K
= -6,589.71%
Cytokinetics Inc's operating profit margin has shown a significant fluctuation over the past five years. The margin has been negative in all years, with the most recent figure for Dec 31, 2023, at -6,589.71%. This indicates that the company's operating expenses exceeded its revenue by a substantial margin. The trend over the period shows a worsening margin from 2019 to 2023, suggesting possible inefficiencies in cost management or declining revenue generation. Further analysis and investigation into the company's operational performance and financial health may be warranted to address these concerning operating profit margin figures.
Peer comparison
Dec 31, 2023